diabetes
Showing NaN - NaN of 86
Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of
Completed
- Acute Ischemic Stroke
- +2 more
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
-
Tucson, Arizona
- +69 more
Dec 13, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Muscle Shoals, Alabama
- +142 more
Nov 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +208 more
Oct 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +149 more
Jul 30, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +85 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Concord, California
- +96 more
Mar 6, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +2 more
-
Glendale, Arizona
- +143 more
Jan 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +108 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Fresno, California
- +90 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin degludec
-
Huntsville, Alabama
- +85 more
Dec 7, 2018
Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +98 more
Dec 7, 2018
Diabetes, Heart Disease, Hypertension Trial in Miami (CARIÑO Project, Enhanced Usual Care)
Completed
- Diabetes
- +2 more
- CARIÑO Project
- Enhanced Usual Care
-
Miami, FloridaUniversity of Miami
Oct 15, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Phoenix, Arizona
- +105 more
Sep 3, 2018
Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +3 more
-
Hueytown, Alabama
- +102 more
Sep 3, 2018
Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- pioglitazone
- inhaled human insulin
-
Ozark, Alabama
- +109 more
Sep 3, 2018
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Type 2 Diabetes, Diabetes Trial in Miami, San Antonio, Renton (REMD-477)
Completed
- Type 2 Diabetes Mellitus
- Diabetes
- REMD-477
-
Miami, Florida
- +2 more
Apr 9, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +301 more
Feb 16, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- placebo
-
Anaheim, California
- +86 more
Sep 26, 2017